export const recommendationInfo = [
    {
        measure: "aab",
        recommendation:"Avoid treating adults diagnosed with bronchitis or bronchiolitis with antibotics.",
        subMeasures: []

    },
    {
        measure: "aise",
        recommendation:"",
        subMeasures: [
            {
                measure: "aise-1",
                recommendation:"To be compliant, ensure that the influenza vaccine is administered between July 1(prior measurement year) and June 30(current measurement year).",
            },
            {
                measure: "aise-2",
                recommendation:"To be compliant, either A) At least 1 Td or Tdap vaccine must be administered at least 9 years prior to measurement year or B) member has to have a history of either Anaphylaxis or Encephalitis due to the diphtheria, tetanus or pertussis vaccine.",
                
            },
            {
                measure: "aise-3",
                recommendation:"To be compliant, confirm that either 1 dose of herpes zoster live vaccine OR 2 doses of herpes zoster recombinant vaccine was administered at least 28 days apart. Vaccines can be given anytime on or after the 50th birthday.",
                
            },
            {
                measure: "aise-4",
                recommendation:"To be compliant, confirm that the 23-valent pneumococcal polysaccharide vaccine was administered on or after the 60th birthday.",
                
            }
        ]
    },
    {
        measure: "adde",
        recommendation:"",
       
        subMeasures: [
            {
                measure: "adde-1",
                recommendation:"To be compliant, ensure that a follow up visit with a practitioner with the authority to prescribe medication is completed 30 days after the index prescription start date (IPSD). Note, the initial ISPD visit does not count as the initiation phase visit.",
                
            },
            {
                measure: "adde-2",
                recommendation:"After the initial follow up visit with a practitioner with the authority to prescribe medication, confirm that at least 2 follow up visits have been completed within 9 months after the index prescription start date (IPSD). Only one of the 2 visits can be an e-visit/virtual check-in.",
                
            }
        ]
    },
    {
        measure: "apme",
        recommendation:"",
       
        subMeasures: [
            {
                measure: "apme-1",
                recommendation:"To be compliant, ensure members are tested at least once for HbA1c. ",
                
            },
            {
                measure: "apme-2",
                recommendation:"To be compliant, ensure members are tested at least once for LDL-C or cholesterol.",
                
            },
            {
                measure: "apme-3",
                recommendation:"To be compliant, ensure members are tested at least once for both blood glucose or HbA1c AND LDL-C or cholesterol.",
                
            }
        ]
    },
    {
        measure: "asfe",
        recommendation:"",
       
        subMeasures: [
            {
                measure: "asfe-1",
                recommendation:"To be compliant, ensure that  members 18 and over with a documented unhealthy alcohol use are screened between January 1 - November 1 of the measurement year.",
                
            },
            {
                measure: "asfe-2",
                recommendation:"To be compliant, confirm that members are receiving alcohol counseling or another form of follow-up care 60 days after the date of the first positive screen for unhealthy alcohol use.",
                
            }
        ]
    },
    {
        measure: "bcse",
        recommendation:"To be compliant, ensure that women between 50-74 receive one or more mammograms between October 1, 2 years before the current measurement year, and the end of the current measurement year.",
        subMeasures: []
    },
    {
        measure: "ccs",
        recommendation:"",
        subMeasures: []
    },
    {
        measure: "cise",
        recommendation:"",
       
        subMeasures: [
            {
                measure: "cise-1",
                recommendation:"To be compliant, confirm that by the child’s 2nd birthday, they have had a) at least 4 DTaP vaccinations (not including the one administered before 42 days after birth, b)  anaphylaxis due to the diphtheria, tetanus or pertussis vaccine and c) encephalitis due to the diphtheria, tetanus or pertussis vaccine.",
                
            },
            {
                measure: "cise-2",
                recommendation:"To be compliant, ensure that by the child’s 2nd birthday, they have had at least 3 IPV vaccinations (not including the one administered 42 days after birth).",
                
            },
            {
                measure: "cise-3",
                recommendation:"To be compliant, confirm that the child has either had at least one MMR vaccination between the 1st and 2nd birthday OR has a history of measles, mumps and rubella illnesses, all before their 2nd birthday.",
                
            },
            {
                measure: "cise-4",
                recommendation:"To be compliant, confirm that by the child’s 2nd birthday, the child has either had at least 3 HiB vaccinations (not including the one administered before 42 days after birth) OR had anaphylaxis from the HiB vaccine.",
                
            },
            {
                measure: "cise-5",
                recommendation:"To be compliant, confirm that by the child’s 2nd birthday, the has either had at least 3 hepatitis B vaccinations (note that the newborn hepatitis B vaccine administered at most 7 days post birth counts towards the 3 hepatitis B vaccinations) OR has a history of hepatitis B illness OR anaphylaxis from the hepatitis B vaccine.",
                
            },
            {
                measure: "cise-6",
                recommendation:"To be compliant, ensure that the child either received at least 1 VZV vaccine between the 1st and 2nd birthday OR has a history of varicella zoster (ie: chicken pox) illness before the 2nd birthday.",
                
            },
            {
                measure: "cise-7",
                recommendation:"To be compliant, ensure that by the child’s 2nd birthday, at least 4 pneumococcal conjugate vaccinations have been administered (not including the one administered before 42 days after birth).",
                
            },
            {
                measure: "cise-8",
                recommendation:"To be compliant, ensure that the child either received at least 1 hepatitis A vaccine between the 1st and 2nd birthday OR has a history of hepatitis A illness before the 2nd birthday.",
                
            },
            {
                measure: "cise-9",
                recommendation:"To be compliant, ensure that the child either received at least 2 doses of the 2-dose rotative vaccine before the 2nd birthday (not including the one administered before 42 days after birth) OR at least 3 doses of the 3-dose rotative vaccine before the 2nd birthday (not including the one administered before 42 days after birth) OR a combination of at least 1 dose of the 2-dose & at least 2 doses of the 3-dose vaccines before the 2nd birthday (not including the one administered before 42 days after birth) OR anaphylaxis from the rotavirus vaccine by the 2nd birthday.",
                
            },
            {
                measure: "cise-10",
                recommendation:"To be compliant, ensure that the child has been administered at least 2 influenza vaccines before the 2nd birthday (not including the one administered before 6 months/180 days after birth). Note that 1 of the 2 vaccinations can be the LAIV vaccination provided on the child’s 2nd birthday - this does not include any LAIV vaccines administered before the 2nd birthday.",
                
            },
            {
                measure: "cise-11",
                recommendation:"Confirm compliance with DTaP, IPV, MMR, HiB, hepatitis B, VZV and pneumococcal vaccinations status.",
                
            },
            {
                measure: "cise-12",
                recommendation:"Confirm compliance with DTaP, IPV, MMR, HiB, hepatitis B, VZV, pneumococcal, hepatitis A and rotavirus vaccinations status.",
                
            },
            {
                measure: "cise-13",
                recommendation:"Confirm compliance with DTaP, IPV, MMR, HiB, hepatitis B, VZV, pneumococcal, hepatitis A, rotavirus and Influenza vaccinations status.",
                
            }
        ]
    },
    {
        measure: "cole",
        recommendation:"To be compliant, confirm one or more screenings for colorectal cancer. Acceptable screenings include a) fecal occult blood test during the measurement year, b) flexible sigmoidoscopy up to 4 years prior to measurement year, c) colonoscopy up to 9 years prior to measurement year, d) CT colonography up to 4 years prior to measurement year or d) FIT-DNA test up to 2 years prior to measurement year.",
       
        subMeasures: []
    },
    {
        measure: "cou",
        recommendation:"",
        subMeasures: [
            {
                measure: "cou-1",
                recommendation:"Avoid dispensing opioid medications to members who have been using opioid prescriptions for 15 days over a 30-day period after the index prescription start date (IPSD).",
                
            },
            {
                measure: "cou-2",
                recommendation:"Avoid dispensing opioid medications to members who have been using opioid prescriptions for 31 days over a 62-day period after the index prescription start date (IPSD).",
                
            }
        ]
    },
    {
        measure: "cwp",
        recommendation:"To be compliant, confirm that for a diagnosis of pharyngitis, an antibiotic was given and the group A streptococcus (strep) test was performed within 7 days of pharyngitis’ diagnosis. A group A streptococcus test (Group A Strep Tests Value Set) in the seven-day period from three days prior to the Episode Date through three days after the Episode Date.",
        subMeasures: []
    },
    {
        measure: "dmse",
        recommendation:"",
       
        subMeasures: [
            {
                measure: "dmse-1",
                recommendation:"To be compliant, confirm that a PHQ-9 score has been recorded during Assessment Period 1 (January 1–April 30).",
            },
            {
                measure: "dmse-2",
                recommendation:"To be compliant, confirm that a PHQ-9 score has been recorded during Assessment Period 2 (May 1–August 31).",
            },
            {
                measure: "dmse-3",
                recommendation:"To be compliant, confirm that a PHQ-9 score has been recorded during Assessment Period 3 ( September 1–December 31).",     
            }
        ]
    },
    {
        measure: "drre",
        recommendation:"",
       
        subMeasures: [
            {
                measure: "drre-1",
                recommendation:"To be compliant, ensure that a follow up PHQ-9 score was documented within 4-8 months of the initial assessment with elevated PHQ-9 score.",
                
            },
            {
                measure: "drre-2",
                recommendation:"The PHQ-9 score should be less than 5 during the follow-up period (4-8 months); this indicates a remission of depression symptoms.",
                
            },
            {
                measure: "drre-3",
                recommendation:"The PHQ-9 score should be 50% lower than the score recorded at the initial assessment; this indicates a response to treatment for depression during the follow-up period (4-8 months prior to IESD).",
                
            }
        ]
    },
    {
        measure: "dsfe",
        recommendation:"",
       
        subMeasures: [
            {
                measure: "dsfe-1",
                recommendation:"To be compliant, ensure that screenings for clinical depression are done using the age-appropriate standardized instrument between January 1-December 1 of the measurement year.",
                
            },
            {
                measure: "dsfe-2",
                recommendation:"To be compliant, confirm that members who had a positive depression screen receive qualifying follow-up care within 30 days.",
                
            }
        ]
    },
    {
        measure: "fum",
        recommendation:"",
        subMeasures: [
            {
                measure: "fum-1",
                recommendation:"To be compliant, confirm that a qualifying follow-up visit occurred within 30 days after the emergency department (ED) visit with a diagnosis of mental health illness and/or intentional self-harm. Note: these include follow-up visits on the date of ED.",
            },
            {
                measure: "fum-2",
                recommendation:"To be compliant, confirm that a qualifying follow-up visit occurred within 7 days after the emergency department (ED) visit with a diagnosis of mental health illness and/or intentional self-harm. Note: these include follow-up visits on the date of ED.",
            }
        ]
    },
    {
        measure: "imae",
        recommendation:"",
       
        subMeasures: [
            {
                measure: "imae-1",
                recommendation:"",
                
            },
            {
                measure: "imae-2",
                recommendation:"",
                
            },
            {
                measure: "imae-3",
                recommendation:"",
                
            },
            {
                measure: "imae-4",
                recommendation:"",
                
            },
            {
                measure: "imae-5",
                recommendation:"",
                
            }
        ]
    },
    {
        measure: "pdse",
        recommendation:"",
       
        subMeasures: [
            {
                measure: "pdse-1",
                recommendation:"To be compliant, confirm deliveries in which members had a documented result for depression screening, using an age-appropriate standardized instrument, performed during the 7–84 days following the date of delivery.",
            },
            {
                measure: "pdse-2",
                recommendation:"To be compliant, confirm deliveries in which members received follow-up care on or up to 30 days after the date of the first positive screen (31 total days).",
                
            }
        ]
    },
    {
        measure: "pnde",
        recommendation:"",
       
        subMeasures: [
            {
                measure: "pnde-1",
                recommendation:"To be compliant, confirm deliveries in which members had a documented result for depression screening, using an age-appropriate standardized screening instrument, performed during pregnancy.",
                
            },
            {
                measure: "pnde-2",
                recommendation:"To be compliant, confirm deliveries in which members received follow-up care on or up to 30 days after the date of the first positive screen (31 total days).",
                
            }
        ]
    },
    {
        measure: "prse",
        recommendation:"",
       
        subMeasures: [
            {
                measure: "prse-1",
                recommendation:"To be compliant, confirm deliveries where members received an adult influenza vaccine on or between July 1 of the year prior to the Measurement Period and the delivery date.",
                
            },
            {
                measure: "prse-2",
                recommendation:"To be compliant, confirm deliveries where members received at least one Tdap vaccine during the pregnancy (including on the delivery date) or confirm deliveries where members had any of the following. Anaphylaxis due to the diphtheria, tetanus or pertussis vaccine on or before the delivery date.  Encephalitis due to the diphtheria, tetanus or pertussis vaccine on or before the delivery date.",
                
            },
            {
                measure: "prse-3",
                recommendation: "To be compliant, confirm deliveries meet criteria for immunization status for both Influenza and Tdap.",
                
            }
        ]
    },
    {
        measure: "psa",
        recommendation:"To be compliant, confirm men 70 years and older are not screened unnecessarily for prostate cancer using prostate-specific antigen (PSA)-based screening.",
       
        subMeasures: []
    },
    {
        measure: "uop",
        recommendation:"",
       
        subMeasures: [
            {
                measure: "uop-1",
                recommendation:"To be compliant, avoid opioid dispensing event with ≥15 days to member with 4 or more different prescribers during the measurement year.",
                
            },
            {
                measure: "uop-2",
                recommendation:"To be compliant, avoid opioid dispensing event to member with 4 or more different pharmacies during the measurement year.",
                
            },
            {
                measure: "uop-3",
                recommendation:"To be compliant, avoid opioid dispensing event with ≥15 days to member with 4 or more different prescribers and 4 or more different pharmacies during the measurement year.",
                
            }
        ]
    },
    {
        measure: "uri",
        recommendation:"",
       
        subMeasures: []
    },
    {
        measure: "composite",
        recommendation:"",
       
        subMeasures: []
    }
];

